Deciphera Pharmaceuticals, Inc. to Present at the JMP Securities Hematology and Oncology Summit
Deciphera Pharmaceuticals (NASDAQ: DCPH) will have its CEO, Steve Hoerter, participate in a virtual fireside chat at the JMP Securities Hematology and Oncology Summit on December 6, 2022, at 10:40 AM ET. A live webcast can be accessed on the Company’s website under the 'Events and Presentations' section, with a replay available for 90 days post-event. Deciphera focuses on innovative cancer treatments and is advancing its proprietary switch-control kinase inhibitor platform, including the approved product QINLOCK® for fourth-line GIST treatment.
- None.
- None.
A live webcast of the fireside chat will be available on the “Events and Presentations” page in the “Investors” section of the Company’s website at https://investors.deciphera.com/events-presentations. A replay will be archived on the Company’s website for 90 days following the presentation.
About
Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advancing multiple product candidates from our platform in clinical studies, QINLOCK® is Deciphera’s switch control inhibitor for the treatment of fourth-line GIST. QINLOCK is approved in
View source version on businesswire.com: https://www.businesswire.com/news/home/20221201005230/en/
Investor Relations:
Deciphera@argotpartners.com
212-600-1902
Media:
david.rosen@argotpartners.com
212-600-1902
Source:
FAQ
What is the date and time of Deciphera Pharmaceuticals' fireside chat?
Where can I watch the live webcast of the Deciphera Pharmaceuticals fireside chat?
What is QINLOCK and who is it for?
How long will the replay of the fireside chat be available?
What company is hosting the virtual fireside chat?
